Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-10-30

AUTHORS

Eline H. Ploumen, Tineke H. Pinxterhuis, Paolo Zocca, Ariel Roguin, Rutger L. Anthonio, Carl E. Schotborgh, Edouard Benit, Adel Aminian, Peter W. Danse, Carine J. M. Doggen, Clemens von Birgelen, Marlies M. Kok

ABSTRACT

BackgroundDiabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are lacking. We assessed 3-year ischemic and bleeding outcomes following treatment with new-generation DES in patients with prediabetes and diabetes as compared to normoglycemia.MethodsFor this post-hoc analysis, we pooled patient-level data of the BIO-RESORT and BIONYX stent trials which both stratified for diabetes at randomization. Both trials were multicenter studies performed in tertiary cardiac centers. Study participants were patients of whom glycemic state was known based on hemoglobin A1c, fasting plasma glucose, or medically treated diabetes. Three-year follow-up was available in 4212/4330 (97.3 %) patients. The main endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.ResultsBaseline cardiovascular risk profiles were progressively abnormal in patients with normoglycemia, prediabetes, and diabetes. The main endpoint occurred in 54/489 patients with prediabetes (11.2 %) and 197/1488 with diabetes (13.7 %), as compared to 142/2,353 with normoglycemia (6.1 %) (HR: 1.89, 95 %-CI 1.38–2.58, p < 0.001, and HR: 2.30, 95 %-CI 1.85–2.86, p < 0.001, respectively). In patients with prediabetes, cardiac death and target vessel revascularization rates were significantly higher (HR: 2.81, 95 %-CI 1.49–5.30, p = 0.001, and HR: 1.92, 95 %-CI 1.29–2.87, p = 0.001), and in patients with diabetes all individual components of the main endpoint were significantly higher than in patients with normoglycemia (all p ≤ 0.001). Results were consistent after adjustment for confounders. Major bleeding rates were significantly higher in patients with prediabetes and diabetes, as compared to normoglycemia (3.9 % and 4.1 % vs. 2.3 %; HR:1.73, 95 %-CI 1.03–2.92, p = 0.040, and HR:1.78, 95 %-CI 1.23–2.57, p = 0.002). However, after adjustment for confounders, differences were no longer significant.ConclusionsNot only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk factors.Trial registration: BIO-RESORT ClinicalTrials.gov: NCT01674803, registered 29-08-2012; BIONYX ClinicalTrials.gov: NCT02508714, registered 27-7-2015. More... »

PAGES

217

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4

DOI

http://dx.doi.org/10.1186/s12933-021-01405-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142277542

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34717627


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Thrombosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prediabetic State", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ploumen", 
        "givenName": "Eline H.", 
        "id": "sg:person.015002444531.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015002444531.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pinxterhuis", 
        "givenName": "Tineke H.", 
        "id": "sg:person.012437210704.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012437210704.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zocca", 
        "givenName": "Paolo", 
        "id": "sg:person.07360604275.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07360604275.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel", 
          "id": "http://www.grid.ac/institutes/grid.6451.6", 
          "name": [
            "Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roguin", 
        "givenName": "Ariel", 
        "id": "sg:person.0624615067.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624615067.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.491363.a", 
          "name": [
            "Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anthonio", 
        "givenName": "Rutger L.", 
        "id": "sg:person.0727014624.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727014624.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Haga Hospital, The Hague, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.413591.b", 
          "name": [
            "Department of Cardiology, Haga Hospital, The Hague, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schotborgh", 
        "givenName": "Carl E.", 
        "id": "sg:person.0634373652.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634373652.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Jessa Hospital, Hasselt, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.414977.8", 
          "name": [
            "Department of Cardiology, Jessa Hospital, Hasselt, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benit", 
        "givenName": "Edouard", 
        "id": "sg:person.0730262371.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730262371.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.413871.8", 
          "name": [
            "Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aminian", 
        "givenName": "Adel", 
        "id": "sg:person.01240141422.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240141422.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415930.a", 
          "name": [
            "Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Danse", 
        "givenName": "Peter W.", 
        "id": "sg:person.0752260563.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260563.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doggen", 
        "givenName": "Carine J. M.", 
        "id": "sg:person.01146757520.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
            "Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Birgelen", 
        "givenName": "Clemens", 
        "id": "sg:person.0600054325.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kok", 
        "givenName": "Marlies M.", 
        "id": "sg:person.0660011420.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00592-015-0746-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039151013", 
          "https://doi.org/10.1007/s00592-015-0746-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40256-018-0295-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106283437", 
          "https://doi.org/10.1007/s40256-018-0295-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12933-020-01173-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132950023", 
          "https://doi.org/10.1186/s12933-020-01173-7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-30", 
    "datePublishedReg": "2021-10-30", 
    "description": "BackgroundDiabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are lacking. We assessed 3-year ischemic and bleeding outcomes following treatment with new-generation DES in patients with prediabetes and diabetes as compared to normoglycemia.MethodsFor this post-hoc analysis, we pooled patient-level data of the BIO-RESORT and BIONYX stent trials which both stratified for diabetes at randomization. Both trials were multicenter studies performed in tertiary cardiac centers. Study participants were patients of whom glycemic state was known based on hemoglobin A1c, fasting plasma glucose, or medically treated diabetes. Three-year follow-up was available in 4212/4330 (97.3\u2009%) patients. The main endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.ResultsBaseline cardiovascular risk profiles were progressively abnormal in patients with normoglycemia, prediabetes, and diabetes. The main endpoint occurred in 54/489 patients with prediabetes (11.2\u2009%) and 197/1488 with diabetes (13.7\u2009%), as compared to 142/2,353 with normoglycemia (6.1\u2009%) (HR: 1.89, 95\u2009%-CI 1.38\u20132.58, p\u00a0<\u00a00.001, and HR: 2.30, 95\u2009%-CI 1.85\u20132.86, p\u00a0<\u00a00.001, respectively). In patients with prediabetes, cardiac death and target vessel revascularization rates were significantly higher (HR: 2.81, 95\u2009%-CI 1.49\u20135.30, p\u00a0=\u00a00.001, and HR: 1.92, 95\u2009%-CI 1.29\u20132.87, p\u00a0=\u00a00.001), and in patients with diabetes all individual components of the main endpoint were significantly higher than in patients with normoglycemia (all p\u00a0\u2264\u00a00.001). Results were consistent after adjustment for confounders. Major bleeding rates were significantly higher in patients with prediabetes and diabetes, as compared to normoglycemia (3.9\u2009% and 4.1\u2009% vs. 2.3\u2009%; HR:1.73, 95\u2009%-CI 1.03\u20132.92, p\u00a0=\u00a00.040, and HR:1.78, 95\u2009%-CI 1.23\u20132.57, p\u00a0=\u00a00.002). However, after adjustment for confounders, differences were no longer significant.ConclusionsNot only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk factors.Trial registration: BIO-RESORT ClinicalTrials.gov: NCT01674803, registered 29-08-2012; BIONYX ClinicalTrials.gov: NCT02508714, registered 27-7-2015.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12933-021-01405-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031021", 
        "issn": [
          "1475-2840"
        ], 
        "name": "Cardiovascular Diabetology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "keywords": [
      "new-generation drug-eluting stents", 
      "drug-eluting stents", 
      "main endpoint", 
      "cardiac death", 
      "glycemic state", 
      "target vessel myocardial infarction", 
      "vessel revascularization rate", 
      "major bleeding rates", 
      "impact of prediabetes", 
      "tertiary cardiac centre", 
      "target vessel failure", 
      "vessel myocardial infarction", 
      "cardiovascular risk profile", 
      "cardiovascular risk factors", 
      "percutaneous coronary intervention", 
      "high-risk population", 
      "patient-level data", 
      "BIO-RESORT", 
      "major bleeding", 
      "vessel revascularization", 
      "revascularization rates", 
      "coronary intervention", 
      "baseline characteristics", 
      "cardiac center", 
      "hemoglobin A1c", 
      "multicenter study", 
      "patient group", 
      "adverse outcomes", 
      "stent trials", 
      "plasma glucose", 
      "myocardial infarction", 
      "bleeding rate", 
      "risk factors", 
      "clinical trials", 
      "prediabetes", 
      "high risk", 
      "patients", 
      "diabetes", 
      "normoglycemia", 
      "routine assessment", 
      "study participants", 
      "risk profile", 
      "stents", 
      "trials", 
      "endpoint", 
      "three years", 
      "confounders", 
      "outcomes", 
      "contemporary stents", 
      "death", 
      "vessel failure", 
      "treatment", 
      "BackgroundDiabetes", 
      "revascularization", 
      "A1C", 
      "bleeding", 
      "infarction", 
      "adjustment", 
      "intervention", 
      "MethodsFor", 
      "differences", 
      "risk", 
      "randomization", 
      "association", 
      "ConclusionsNot", 
      "glucose", 
      "rate", 
      "participants", 
      "failure", 
      "group", 
      "population", 
      "assessment", 
      "management", 
      "factors", 
      "data", 
      "center", 
      "study", 
      "individual components", 
      "events", 
      "profile", 
      "impact", 
      "analysis", 
      "results", 
      "characteristics", 
      "state", 
      "components", 
      "dissimilarity", 
      "composites"
    ], 
    "name": "Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials", 
    "pagination": "217", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142277542"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12933-021-01405-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34717627"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12933-021-01405-4", 
      "https://app.dimensions.ai/details/publication/pub.1142277542"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_897.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12933-021-01405-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12933-021-01405-4'


 

This table displays all metadata directly associated to this object as RDF triples.

347 TRIPLES      21 PREDICATES      138 URIs      126 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12933-021-01405-4 schema:about N11ba71cda4be4327959079fb0956cf2b
2 N13374cce25dc4daa863a46089a00ae84
3 N1d52d3e1fc804e6e9dc85d5947ab8504
4 N2b56abe8aee443908508ae1d23dc731f
5 N35cb685f850d40cb8d7a37bd4ac2a60c
6 N3af95eb8684a4431813db383b2146381
7 N3f9e04706080420f8703925e5d05ba69
8 N4982504847ea48a3aa7a93124365abc5
9 N6166fccd28634487adb9233ef1f5417f
10 N64c900f9ac844ac08cdef8f82c3f512a
11 N6b178acae6e14d73a4ce5c572be8de15
12 N7ee4cd53740d4895bb72a21f110ed3cb
13 N8a9d0a4ebd514d619bcacae870429f5b
14 N928a40155b3a49d5a86e401916210db1
15 Na388a45a2b8c43eb9928cdd2e60a158c
16 Naa85934c58b1494a875c6e5d451b8fe1
17 Nab2e0618456445679ededa4768e39a80
18 Nb6508c42266a4a5db17b78149b5c701e
19 Nbdb836acaf934a9e934f80db1f81e5c1
20 Nbe09095e821845feb14ede3a0ef5e00d
21 Ne03285f13d8a4e97aa6a51a146c9ba4f
22 anzsrc-for:11
23 anzsrc-for:1102
24 anzsrc-for:1103
25 schema:author N8adf78cb42a9492484da7bc783b258ea
26 schema:citation sg:pub.10.1007/s00592-015-0746-8
27 sg:pub.10.1007/s40256-018-0295-y
28 sg:pub.10.1186/s12933-020-01173-7
29 schema:datePublished 2021-10-30
30 schema:datePublishedReg 2021-10-30
31 schema:description BackgroundDiabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are lacking. We assessed 3-year ischemic and bleeding outcomes following treatment with new-generation DES in patients with prediabetes and diabetes as compared to normoglycemia.MethodsFor this post-hoc analysis, we pooled patient-level data of the BIO-RESORT and BIONYX stent trials which both stratified for diabetes at randomization. Both trials were multicenter studies performed in tertiary cardiac centers. Study participants were patients of whom glycemic state was known based on hemoglobin A1c, fasting plasma glucose, or medically treated diabetes. Three-year follow-up was available in 4212/4330 (97.3 %) patients. The main endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization.ResultsBaseline cardiovascular risk profiles were progressively abnormal in patients with normoglycemia, prediabetes, and diabetes. The main endpoint occurred in 54/489 patients with prediabetes (11.2 %) and 197/1488 with diabetes (13.7 %), as compared to 142/2,353 with normoglycemia (6.1 %) (HR: 1.89, 95 %-CI 1.38–2.58, p < 0.001, and HR: 2.30, 95 %-CI 1.85–2.86, p < 0.001, respectively). In patients with prediabetes, cardiac death and target vessel revascularization rates were significantly higher (HR: 2.81, 95 %-CI 1.49–5.30, p = 0.001, and HR: 1.92, 95 %-CI 1.29–2.87, p = 0.001), and in patients with diabetes all individual components of the main endpoint were significantly higher than in patients with normoglycemia (all p ≤ 0.001). Results were consistent after adjustment for confounders. Major bleeding rates were significantly higher in patients with prediabetes and diabetes, as compared to normoglycemia (3.9 % and 4.1 % vs. 2.3 %; HR:1.73, 95 %-CI 1.03–2.92, p = 0.040, and HR:1.78, 95 %-CI 1.23–2.57, p = 0.002). However, after adjustment for confounders, differences were no longer significant.ConclusionsNot only patients with diabetes but also patients with prediabetes represent a high-risk population. After treatment with new-generation DES, both patient groups had higher risks of ischemic and bleeding events. Differences in major bleeding were mainly attributable to dissimilarities in baseline characteristics. Routine assessment of glycemic state may help to identify patients with prediabetes for intensified management of cardiovascular risk factors.Trial registration: BIO-RESORT ClinicalTrials.gov: NCT01674803, registered 29-08-2012; BIONYX ClinicalTrials.gov: NCT02508714, registered 27-7-2015.
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf N9168e89f01424d1f9e235bde76aad7eb
35 Na8cbd14b07484956af51c531d7ccdc20
36 sg:journal.1031021
37 schema:keywords A1C
38 BIO-RESORT
39 BackgroundDiabetes
40 ConclusionsNot
41 MethodsFor
42 adjustment
43 adverse outcomes
44 analysis
45 assessment
46 association
47 baseline characteristics
48 bleeding
49 bleeding rate
50 cardiac center
51 cardiac death
52 cardiovascular risk factors
53 cardiovascular risk profile
54 center
55 characteristics
56 clinical trials
57 components
58 composites
59 confounders
60 contemporary stents
61 coronary intervention
62 data
63 death
64 diabetes
65 differences
66 dissimilarity
67 drug-eluting stents
68 endpoint
69 events
70 factors
71 failure
72 glucose
73 glycemic state
74 group
75 hemoglobin A1c
76 high risk
77 high-risk population
78 impact
79 impact of prediabetes
80 individual components
81 infarction
82 intervention
83 main endpoint
84 major bleeding
85 major bleeding rates
86 management
87 multicenter study
88 myocardial infarction
89 new-generation drug-eluting stents
90 normoglycemia
91 outcomes
92 participants
93 patient group
94 patient-level data
95 patients
96 percutaneous coronary intervention
97 plasma glucose
98 population
99 prediabetes
100 profile
101 randomization
102 rate
103 results
104 revascularization
105 revascularization rates
106 risk
107 risk factors
108 risk profile
109 routine assessment
110 state
111 stent trials
112 stents
113 study
114 study participants
115 target vessel failure
116 target vessel myocardial infarction
117 tertiary cardiac centre
118 three years
119 treatment
120 trials
121 vessel failure
122 vessel myocardial infarction
123 vessel revascularization
124 vessel revascularization rate
125 schema:name Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
126 schema:pagination 217
127 schema:productId N22815a3696d4439b97338de622bf839f
128 N98f5f5d6e2ef49949af5ebfba71d27b6
129 Nf9508ac7c18f40e78d36cc6e68d194b5
130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142277542
131 https://doi.org/10.1186/s12933-021-01405-4
132 schema:sdDatePublished 2022-08-04T17:10
133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
134 schema:sdPublisher N9d97b6a4495f409f8c35d1a2fbae7daa
135 schema:url https://doi.org/10.1186/s12933-021-01405-4
136 sgo:license sg:explorer/license/
137 sgo:sdDataset articles
138 rdf:type schema:ScholarlyArticle
139 N0faea3643f334171843a6d4bc473d262 rdf:first sg:person.01240141422.07
140 rdf:rest Nc7863d344508413691b3c511dbd3b38e
141 N11ba71cda4be4327959079fb0956cf2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Female
143 rdf:type schema:DefinedTerm
144 N13374cce25dc4daa863a46089a00ae84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Humans
146 rdf:type schema:DefinedTerm
147 N1d52d3e1fc804e6e9dc85d5947ab8504 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Risk Assessment
149 rdf:type schema:DefinedTerm
150 N22815a3696d4439b97338de622bf839f schema:name dimensions_id
151 schema:value pub.1142277542
152 rdf:type schema:PropertyValue
153 N2b56abe8aee443908508ae1d23dc731f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Glycated Hemoglobin A
155 rdf:type schema:DefinedTerm
156 N35629be1b2bf4c7cbcc643c3049a835f rdf:first sg:person.07360604275.78
157 rdf:rest Ncf83426526e94871bb76cc9ae9f9ac74
158 N35cb685f850d40cb8d7a37bd4ac2a60c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Coronary Artery Disease
160 rdf:type schema:DefinedTerm
161 N3af95eb8684a4431813db383b2146381 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Diabetes Mellitus
163 rdf:type schema:DefinedTerm
164 N3f9e04706080420f8703925e5d05ba69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Hemorrhage
166 rdf:type schema:DefinedTerm
167 N462c8ac919794680993313812e211e8f rdf:first sg:person.0727014624.50
168 rdf:rest Nbe732f616ed54b9cabbaeaf016ae52fa
169 N4982504847ea48a3aa7a93124365abc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Coronary Thrombosis
171 rdf:type schema:DefinedTerm
172 N6166fccd28634487adb9233ef1f5417f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Prediabetic State
174 rdf:type schema:DefinedTerm
175 N64c900f9ac844ac08cdef8f82c3f512a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Drug-Eluting Stents
177 rdf:type schema:DefinedTerm
178 N6b178acae6e14d73a4ce5c572be8de15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Blood Glucose
180 rdf:type schema:DefinedTerm
181 N7ee4cd53740d4895bb72a21f110ed3cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Male
183 rdf:type schema:DefinedTerm
184 N8a9d0a4ebd514d619bcacae870429f5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Hypoglycemic Agents
186 rdf:type schema:DefinedTerm
187 N8adf78cb42a9492484da7bc783b258ea rdf:first sg:person.015002444531.78
188 rdf:rest Nd6bd6493c07c4e39a4737f6ac82107da
189 N9168e89f01424d1f9e235bde76aad7eb schema:issueNumber 1
190 rdf:type schema:PublicationIssue
191 N928a40155b3a49d5a86e401916210db1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Prosthesis Design
193 rdf:type schema:DefinedTerm
194 N98f5f5d6e2ef49949af5ebfba71d27b6 schema:name doi
195 schema:value 10.1186/s12933-021-01405-4
196 rdf:type schema:PropertyValue
197 N9d97b6a4495f409f8c35d1a2fbae7daa schema:name Springer Nature - SN SciGraph project
198 rdf:type schema:Organization
199 N9f13f71d4b8c4d17a40fdfc33a36e34c rdf:first sg:person.0600054325.83
200 rdf:rest Na246faecab554bc69f59313fe0c145fc
201 Na1a575f5cc374e6cacee412ac46d514a rdf:first sg:person.0730262371.12
202 rdf:rest N0faea3643f334171843a6d4bc473d262
203 Na246faecab554bc69f59313fe0c145fc rdf:first sg:person.0660011420.13
204 rdf:rest rdf:nil
205 Na388a45a2b8c43eb9928cdd2e60a158c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Risk Factors
207 rdf:type schema:DefinedTerm
208 Na8cbd14b07484956af51c531d7ccdc20 schema:volumeNumber 20
209 rdf:type schema:PublicationVolume
210 Naa85934c58b1494a875c6e5d451b8fe1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Percutaneous Coronary Intervention
212 rdf:type schema:DefinedTerm
213 Nab2e0618456445679ededa4768e39a80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Time Factors
215 rdf:type schema:DefinedTerm
216 Nb6508c42266a4a5db17b78149b5c701e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Middle Aged
218 rdf:type schema:DefinedTerm
219 Nbdb836acaf934a9e934f80db1f81e5c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Randomized Controlled Trials as Topic
221 rdf:type schema:DefinedTerm
222 Nbe09095e821845feb14ede3a0ef5e00d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Aged
224 rdf:type schema:DefinedTerm
225 Nbe732f616ed54b9cabbaeaf016ae52fa rdf:first sg:person.0634373652.04
226 rdf:rest Na1a575f5cc374e6cacee412ac46d514a
227 Nc7863d344508413691b3c511dbd3b38e rdf:first sg:person.0752260563.26
228 rdf:rest Nf66e2f0ea7d34e8ea7a52a750ba63826
229 Ncf83426526e94871bb76cc9ae9f9ac74 rdf:first sg:person.0624615067.52
230 rdf:rest N462c8ac919794680993313812e211e8f
231 Nd6bd6493c07c4e39a4737f6ac82107da rdf:first sg:person.012437210704.63
232 rdf:rest N35629be1b2bf4c7cbcc643c3049a835f
233 Ne03285f13d8a4e97aa6a51a146c9ba4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Treatment Outcome
235 rdf:type schema:DefinedTerm
236 Nf66e2f0ea7d34e8ea7a52a750ba63826 rdf:first sg:person.01146757520.17
237 rdf:rest N9f13f71d4b8c4d17a40fdfc33a36e34c
238 Nf9508ac7c18f40e78d36cc6e68d194b5 schema:name pubmed_id
239 schema:value 34717627
240 rdf:type schema:PropertyValue
241 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
242 schema:name Medical and Health Sciences
243 rdf:type schema:DefinedTerm
244 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
245 schema:name Cardiorespiratory Medicine and Haematology
246 rdf:type schema:DefinedTerm
247 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
248 schema:name Clinical Sciences
249 rdf:type schema:DefinedTerm
250 sg:journal.1031021 schema:issn 1475-2840
251 schema:name Cardiovascular Diabetology
252 schema:publisher Springer Nature
253 rdf:type schema:Periodical
254 sg:person.01146757520.17 schema:affiliation grid-institutes:grid.6214.1
255 schema:familyName Doggen
256 schema:givenName Carine J. M.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17
258 rdf:type schema:Person
259 sg:person.01240141422.07 schema:affiliation grid-institutes:grid.413871.8
260 schema:familyName Aminian
261 schema:givenName Adel
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240141422.07
263 rdf:type schema:Person
264 sg:person.012437210704.63 schema:affiliation grid-institutes:grid.6214.1
265 schema:familyName Pinxterhuis
266 schema:givenName Tineke H.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012437210704.63
268 rdf:type schema:Person
269 sg:person.015002444531.78 schema:affiliation grid-institutes:grid.6214.1
270 schema:familyName Ploumen
271 schema:givenName Eline H.
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015002444531.78
273 rdf:type schema:Person
274 sg:person.0600054325.83 schema:affiliation grid-institutes:grid.6214.1
275 schema:familyName von Birgelen
276 schema:givenName Clemens
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83
278 rdf:type schema:Person
279 sg:person.0624615067.52 schema:affiliation grid-institutes:grid.6451.6
280 schema:familyName Roguin
281 schema:givenName Ariel
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624615067.52
283 rdf:type schema:Person
284 sg:person.0634373652.04 schema:affiliation grid-institutes:grid.413591.b
285 schema:familyName Schotborgh
286 schema:givenName Carl E.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634373652.04
288 rdf:type schema:Person
289 sg:person.0660011420.13 schema:affiliation grid-institutes:grid.415214.7
290 schema:familyName Kok
291 schema:givenName Marlies M.
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13
293 rdf:type schema:Person
294 sg:person.0727014624.50 schema:affiliation grid-institutes:grid.491363.a
295 schema:familyName Anthonio
296 schema:givenName Rutger L.
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727014624.50
298 rdf:type schema:Person
299 sg:person.0730262371.12 schema:affiliation grid-institutes:grid.414977.8
300 schema:familyName Benit
301 schema:givenName Edouard
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730262371.12
303 rdf:type schema:Person
304 sg:person.07360604275.78 schema:affiliation grid-institutes:grid.415214.7
305 schema:familyName Zocca
306 schema:givenName Paolo
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07360604275.78
308 rdf:type schema:Person
309 sg:person.0752260563.26 schema:affiliation grid-institutes:grid.415930.a
310 schema:familyName Danse
311 schema:givenName Peter W.
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260563.26
313 rdf:type schema:Person
314 sg:pub.10.1007/s00592-015-0746-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039151013
315 https://doi.org/10.1007/s00592-015-0746-8
316 rdf:type schema:CreativeWork
317 sg:pub.10.1007/s40256-018-0295-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1106283437
318 https://doi.org/10.1007/s40256-018-0295-y
319 rdf:type schema:CreativeWork
320 sg:pub.10.1186/s12933-020-01173-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132950023
321 https://doi.org/10.1186/s12933-020-01173-7
322 rdf:type schema:CreativeWork
323 grid-institutes:grid.413591.b schema:alternateName Department of Cardiology, Haga Hospital, The Hague, Netherlands
324 schema:name Department of Cardiology, Haga Hospital, The Hague, Netherlands
325 rdf:type schema:Organization
326 grid-institutes:grid.413871.8 schema:alternateName Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium
327 schema:name Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium
328 rdf:type schema:Organization
329 grid-institutes:grid.414977.8 schema:alternateName Department of Cardiology, Jessa Hospital, Hasselt, Belgium
330 schema:name Department of Cardiology, Jessa Hospital, Hasselt, Belgium
331 rdf:type schema:Organization
332 grid-institutes:grid.415214.7 schema:alternateName Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands
333 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands
334 rdf:type schema:Organization
335 grid-institutes:grid.415930.a schema:alternateName Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands
336 schema:name Department of Cardiology, Rijnstate Hospital, Arnhem, Netherlands
337 rdf:type schema:Organization
338 grid-institutes:grid.491363.a schema:alternateName Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands
339 schema:name Department of Cardiology, Treant Zorggroep, Scheper Hospital, Emmen, Netherlands
340 rdf:type schema:Organization
341 grid-institutes:grid.6214.1 schema:alternateName Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands
342 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands
343 Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, Netherlands
344 rdf:type schema:Organization
345 grid-institutes:grid.6451.6 schema:alternateName Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel
346 schema:name Department of Cardiology, Hadera and B. Rappaport-Faculty of Medicine, Hillel Yaffe Medical Center, Israel Institute of Technology, Haifa, Israel
347 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...